Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis

被引:12
|
作者
Li, W. -B. [1 ]
Zhou, J. [1 ]
Xu, L. [1 ]
Su, X. -L. [2 ]
Liu, Q. [1 ]
Pang, H. [1 ]
机构
[1] Med Univ, Affiliated Hosp Chongqing 1, Dept Nucl Med, Chongqing, Peoples R China
[2] Med Univ, Affiliated Hosp Chongqing 1, Dept Endocrine Breast Surg, Chongqing, Peoples R China
关键词
papillary thyroid carcinoma; integrated analysis; differentially expressed genes; WILMS-TUMOR; EXPRESSION; CANCER; ACTIVATION; PROGRESSION; MECHANISMS; NEOPLASMS; FIBULINS; RECEPTOR; CADHERIN;
D O I
10.1055/s-0035-1569289
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Papillary thyroid carcinoma (PTC) is the most common type of thyroid carcinoma, and our understanding of its pathogenesis is incomplete. To elucidate the mechanisms underlying such progression and identify novel diagnostic markers, we aimed to discover the underlying gene associated with PTC. Integrated analysis of microarray datasets was performed to identify differentially expressed genes (DEGs) between PTCs and normal tissues. GO enrichment analysis and KEGG pathway enrichment analysis were then performed to uncover the functions of DEGs. Furthermore, the protein-protein interaction (PPI) network of DEGs was constructed. Five GEO datasets were obtained. Totally, 154 DEGs across the studies were identified, including 26 upregulated and 128 downregulated DEGs. In the PPI network, MLLT1, DLG2, and EFEMP1 were the hub proteins, in which DLG2 and EFEMP1 were involved in tumor progression. Among the top 10 up- and downregulated genes, the dysregulation genes of TPO, CDH16, and MPPED2 may be closely related to the tumorigenesis of PTC. By integrated analysis of multiple gene expression profiles, we propose that the dysregulation genes of TPO and MPPED2 will be the promising diagnostic markers for PTCs.
引用
收藏
页码:226 / 231
页数:6
相关论文
共 50 条
  • [41] Network Analyses of Integrated Differentially Expressed Genes in Papillary Thyroid Carcinoma to Identify Characteristic Genes
    Shang, Junliang
    Ding, Qian
    Yuan, Shasha
    Liu, Jin-Xing
    Li, Feng
    Zhang, Honghai
    GENES, 2019, 10 (01):
  • [42] Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis
    Hu, Shengqing
    Liao, Yunfei
    Chen, Lulu
    MEDICAL SCIENCE MONITOR, 2018, 24 : 6438 - 6448
  • [43] In silico identification of novel non-synonymous variants in metabolic pathway associated target genes of papillary thyroid carcinoma: A way towards future treatment of papillary thyroid carcinoma
    Ray, Manisha
    Sarkar, Saurav
    META GENE, 2020, 24
  • [44] Immunohistochemical diagnosis of papillary thyroid carcinoma
    Cheung, CC
    Ezzat, S
    Freeman, JL
    Rosen, IB
    Asa, SL
    MODERN PATHOLOGY, 2001, 14 (04) : 338 - 342
  • [45] Sonographic diagnosis of papillary thyroid carcinoma
    Al-Tamami, M
    Al-Khawari, H
    Al-Sayer, H
    Jumaa, T
    MEDICAL PRINCIPLES AND PRACTICE, 2000, 9 (01) : 25 - 34
  • [46] DIAGNOSIS OF PAPILLARY THYROID-CARCINOMA
    TROFIMOVA, EB
    PAVLOVSKAYA, AI
    ARKHIV PATOLOGII, 1992, 54 (02) : 25 - 30
  • [47] Pitfalls in the diagnosis of papillary carcinoma of the thyroid
    Kulacoglu, S
    Ashton-Key, M
    Buley, I
    CYTOPATHOLOGY, 1998, 9 (03) : 193 - 200
  • [48] Thyroid hemiatrophy associated with papillary thyroid carcinoma
    Seko, Takuya
    Kato, Hiroki
    Ando, Tomohiro
    Kobayashi, Kazuhiro
    Shibata, Hirofumi
    Ogawa, Takenori
    Kawaguchi, Masaya
    Noda, Yoshifumi
    Hyodo, Fuminori
    Matsuo, Masayuki
    NEURORADIOLOGY, 2024, 66 (10) : 1795 - 1803
  • [49] Cribriform-morular variant of papillary thyroid carcinoma (PTC): The sporadic counterpart of familial adenomatous polyposis (FAP)-associated thyroid carcinoma
    Chan, JKC
    Cameselle-Teijeiro, J
    LABORATORY INVESTIGATION, 1999, 79 (01) : 67A - 67A
  • [50] Analysis of BRAF point mutation and RET/PTC rearrangement refines the fine-needle aspiration diagnosis of papillary thyroid carcinoma
    Salvatore, G
    Giannini, R
    Faviana, P
    Caleo, A
    Migliaccio, I
    Fagin, JA
    Nikiforov, YE
    Troncone, G
    Palombini, L
    Basolo, F
    Santoro, M
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (10): : 5175 - 5180